Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
00874
Company Profile
- Business description- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segments include Great Southern TCM; Great Health; Great Commerce and Great Medical Care. The company generates maximum revenue from the Great Commerce segment. 
- Contact- 45 Sha Mian North Street 
 Liwan District
 Guangdong Province
 Guangzhou510130
 CHN- T: +86 2066281218 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Distribution - Fiscal Year End- 31 December 2025 - Employees- 27,425 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
We think Microsoft stock is moderately undervalued.
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,157.29 | 43.59 | -0.53% | 
| DAX 40 | 24,118.89 | 5.32 | -0.02% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,760.06 | 3.92 | 0.04% | 
| HKSE | 25,999.70 | 282.99 | -1.08% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 52,244.44 | 918.83 | 1.79% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,955.92 | 30.98 | -0.78% |